Included in the formulation
АТХ:L.03.A.X Other immunostimulants
Pharmacodynamics:Stimulates T-lymphocytes; induces the formation of endogenous interferon; increases the content IgA, including in the urine. Clinical studies have shown that the drug reduces the frequency of recurrence of infections of the urinary tract, especially cystitis.
Pharmacokinetics:Not studied.
Indications:Combined treatment and prevention of recurrences of chronic urinary tract infection, especially cystitis, regardless of the nature of the microorganism, combined with antibiotics or antiseptics in adults and children from the age of four.
XIV.N10-N16.N11 Chronic tubulointerstitial nephritis
XIV.N30-N39.N30 Cystitis
XIV.N30-N39.N34 Urethritis and urethral syndrome
XXI.Z20-Z29.Z29.8 Other specified preventive measures
Contraindications:Hypersensitivity, children's age (up to 4 years), breast-feeding.
Pregnancy and lactation:Not recommended for use during pregnancy and during breastfeeding.
FDA recommendations are not defined.
Dosing and Administration:For therapeutic purposes, 1 capsule is given on a daily basis in the morning on an empty stomach as an additional drug for routine antimicrobial therapy until the symptoms disappear, but not less than 10 days. The maximum duration of treatment is 3 months.
To prevent the recurrence of chronic infection of the urinary tract, 1 capsule is prescribed daily in the morning on an empty stomach for 3 months.
In case the child is difficult to swallow the capsule, it should be opened and mixed with the drink (fruit juice, milk and so on).
The duration of treatment or the appointment of a second course of therapy is determined individually, based on the general condition of the patient.
Side effects:From the digestive system: often (from 1 to 10%) - diarrhea, nausea, dyspepsia, including a feeling of discomfort in the epigastric region; infrequently (from 0,1 to 1%) - pain in the abdomen.
From the nervous system: often (from 1 to 10%) is a headache.
From the skin and subcutaneous tissue: infrequently (from 0,1 to 1%) - allergic reactions (rash, itching, unexpressed exanthema).
Violations of a general nature: infrequently (from 0,1 to 1%) - a fever.
Single cases of serious adverse events, such as oral edema and peripheral edema, as well as the development of alopecia have been reported. When skin reactions occur, fever (in the case of isolated or unexplained fever (above 38 ° C) occurring at the beginning of treatment) or edema should be discontinued, as these symptoms may be signs of an allergic reaction.
Overdose:No data on overdose.
Interaction:Interactions with other drugs have not been established to date.
As a precaution, do not use the drug 2 weeks before and within 2 weeks after ingestion of live vaccines.
Immunosuppressive drugs may affect the effect of the drug.
Special instructions:Does not affect the ability to drive vehicles and mechanisms.